Linezolid and rifampin:: Drug interaction contrary to expectations?

被引：55

作者：

Egle, H ^{[1
]}

Trittler, R

Kümmerer, K

Lemmen, SW

机构：

[1] Univ Hosp Freiburg, Inst Environm Med & Hosp Epidemiol, Freiburg, Germany

[2] Univ Hosp Aachen, Dept Infect Control, Aachen, Germany

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 05期

关键词：

D O I：

10.1016/j.clpt.2005.01.020

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：451 / 453

页数：3

共 5 条

[1] Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions? [J].

Collett, A ;

Tanianis-Hughes, J ;

Warhurst, G .

BIOCHEMICAL PHARMACOLOGY, 2004, 68 (04) :783-790

[2] CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects [J].

Giessmann, T ;

Modess, C ;

Hecker, U ;

Zschiesche, M ;

Dazert, P ;

Kunert-Keil, C ;

Warzok, R ;

Engel, G ;

Weitschies, W ;

Cascorbi, I ;

Kroemer, HK ;

Siegmund, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (03) :213-222

[3] Population pharmacokinetics of linezolid in patients treated in a compassionate-use program [J].

Meagher, AK ;

Forrest, A ;

Rayner, CR ;

Birmingham, MC ;

Schentag, JJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :548-553

[4]

Slatter JG, 2001, DRUG METAB DISPOS, V29, P1136

[5]

Wynalda MA, 2000, DRUG METAB DISPOS, V28, P1014

← 1 →